STEKENE PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
STEKENE PHARMA
Largest movements
- Tangible fixed assets -€49,700
down €49,700 (-7.1%), from €698,363 to €648,663
of which Land and buildings: -€33,453
- Receivables within one year +€27,704
up €27,704 (+31.2%), from €88,710 to €116,415
of which Trade receivables: +€28,911
- Other debts -€92,147
down €92,147 (-25.2%), from €366,338 to €274,191
- Reserves +€51,818
up €51,818 (+12.3%), from €421,270 to €473,089
- Trade debts +€17,190
up €17,190 (+17.7%), from €97,168 to €114,359
- Tax, wage and social debts +€9,394
up €9,394 (+61.3%), from €15,329 to €24,723
of which Taxes: +€8,808
- Gross operating margin +€33,441
up €33,441 (+14.4%), from €232,222 to €265,664
- Taxes +€9,032
up €9,032 (+92.4%), from €9,775 to €18,808
- Financial charges -€9,011
down €9,011 (-42.7%), from €21,105 to €12,094
- Staff costs +€3,284
up €3,284 (+2.8%), from €117,964 to €121,248
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €912,505 | €898,762 | -€13,743 | -1.5% |
| Fixed assets | 21/28 | €698,363 | €648,663 | -€49,700 | -7.1% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €698,363 | €648,663 | -€49,700 | -7.1% |
| Land and buildings | 22 | €650,761 | €617,308 | -€33,453 | -5.1% |
| Plant, machinery and equipment | 23 | €44,112 | €23,319 | -€20,793 | -47.1% |
| Furniture and vehicles | 24 | €3,490 | €8,035 | +€4,546 | +130.2% |
| Current assets | 29/58 | €214,142 | €250,099 | +€35,957 | +16.8% |
| Stocks and contracts in progress | 3 | €111,589 | €120,534 | +€8,945 | +8.0% |
| Stocks | 30/36 | €111,589 | €120,534 | +€8,945 | +8.0% |
| Amounts receivable within one year | 40/41 | €88,710 | €116,415 | +€27,704 | +31.2% |
| Trade receivables | 40 | €86,270 | €115,182 | +€28,911 | +33.5% |
| Other amounts receivable | 41 | €2,440 | €1,233 | -€1,207 | -49.5% |
| Cash at bank and in hand | 54/58 | €13,842 | €13,150 | -€692 | -5.0% |
| Total equity and liabilities | 10/49 | €912,505 | €898,762 | -€13,743 | -1.5% |
| Equity | 10/15 | €433,670 | €485,489 | +€51,818 | +11.9% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €421,270 | €473,089 | +€51,818 | +12.3% |
| Distributable reserves | 133 | €421,270 | €473,089 | +€51,818 | +12.3% |
| Amounts payable | 17/49 | €478,835 | €413,273 | -€65,562 | -13.7% |
| Amounts payable within one year | 42/48 | €478,835 | €413,273 | -€65,562 | -13.7% |
| Trade debts | 44 | €97,168 | €114,359 | +€17,190 | +17.7% |
| Suppliers | 440/4 | €97,168 | €114,359 | +€17,190 | +17.7% |
| Taxes, remuneration and social security | 45 | €15,329 | €24,723 | +€9,394 | +61.3% |
| Taxes | 450/3 | - | €8,808 | +€8,808 | |
| Remuneration and social security | 454/9 | €15,329 | €15,916 | +€587 | +3.8% |
| Other amounts payable | 47/48 | €366,338 | €274,191 | -€92,147 | -25.2% |
| Remuneration, social security and pensions | 62 | €117,964 | €121,248 | +€3,284 | +2.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €55,602 | €57,001 | +€1,399 | +2.5% |
| Other operating charges | 640/8 | €4,506 | €6,322 | +€1,815 | +40.3% |
| Gross operating margin | 9900 | €232,222 | €265,664 | +€33,441 | +14.4% |
| Operating profit (loss) | 9901 | €54,151 | €81,093 | +€26,943 | +49.8% |
| Financial income | 75/76B | €1,714 | €1,627 | -€87 | -5.1% |
| Recurring financial income | 75 | €1,714 | €1,627 | -€87 | -5.1% |
| Financial charges | 65/66B | €21,105 | €12,094 | -€9,011 | -42.7% |
| Recurring financial charges | 65 | €21,105 | €12,094 | -€9,011 | -42.7% |
| Profit (loss) for the period before taxes | 9903 | €34,759 | €70,626 | +€35,867 | +103.2% |
| Income taxes | 67/77 | €9,775 | €18,808 | +€9,032 | +92.4% |
| Profit (loss) for the period | 9904 | €24,984 | €51,818 | +€26,834 | +107.4% |
| Profit (loss) for the period to be appropriated | 9905 | €24,984 | €51,818 | +€26,834 | +107.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.